Status:
UNKNOWN
Safety Validation of EndoSWIR Device
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
Institut National de la Santé et de la Recherche Médicale, Institute for Advanced Biosciences
Commissariat A L'energie Atomique
Conditions:
Optical Guided Surgery
Eligibility:
All Genders
18+ years
Brief Summary
Head and neck cancer has an incidence of 600,000 cases per year worldwide (6th among cancers) and cause 380,000 death per year. Surgical resection is guided by the surgeon's inspection and palpation o...
Detailed Description
ENDOSWIR dispositive is a InGaAs (Indium Gallium Arsenide) camera working at ambient temperature. The light is a quartz-tungstene-halogeno (QTH) source and the collected beam is filtered to illuminate...
Eligibility Criteria
Inclusion
- Tonsillectomy
Exclusion
- suspicion of Head-and neck cancer
Key Trial Info
Start Date :
July 21 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04274309
Start Date
July 21 2020
End Date
May 1 2021
Last Update
July 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chu Grenoble Alpes
Grenoble, France, 38043